期刊文献+

乙脑病毒包膜蛋白可溶性表达及纯化 被引量:1

Expression and purification of the soluble envelope protein of Japanese encephalitis virus
原文传递
导出
摘要 目的:通过原核表达载体对乙脑病毒包膜蛋白进行可溶性表达和纯化。方法筛选不同的表达载体、宿主菌株、表达条件,以获得可溶性的目的蛋白表达。采用镍柱和凝胶过滤层析对表达蛋白进行纯化。结果对不同的载体、菌株、表达条件筛选后,最终发现PBCX载体与乙脑病毒包膜蛋白E406基因连接后的质粒,在低温诱导后获得可溶性E蛋白表达,且表达量较高。表达量占可溶性蛋白总量的23%。通过镍柱和凝胶过滤层析纯化后,目的蛋白纯度较高,达85%,满足试验需求。结论本研究获得了可溶性表达的乙脑病毒E蛋白,方法简单高效,为深入研究该蛋白生物学特性和功能,解析乙脑病毒的致病机制、乙脑减毒活疫苗毒株的减毒机制及其质量控制,乙脑诊断试剂开发,奠定了技术基础。 Objective To express and purify the envelope ( E) protein of Japanese encephalitis virus (JEV) in soluble form.Methods Various prokaryotic expression vectors , host strains and induction conditions including time and temperatures were screened to obtain an optimum prokaryotic expression system for JEV E protein in soluble form .The expressed protein was purified by using nickel column chromatography and gel filtration chromatography .Results The soluble JEV E protein , accounting for 23% of the totally bacteria soluble protein was effectively expressed by using the recombinant plasmid PBCX -E406 at low tem-perature.The purity of the expressed protein reached up to 85%after the purification by using nickel column and gel filtration chromatography .Conclusion Soluble JEV E protein was successfully expressed and purified in a simple and efficient way .It would provide a useful tool for further investigation on JEV infection , attenuation mechanism of JE live vaccine strain SA 14-14-2 and the quality control of JE vaccine .It can also be used for the development of diagnosis assay for JEV .
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2014年第7期546-550,共5页 Chinese Journal of Microbiology and Immunology
关键词 乙脑病毒 包膜蛋白 可溶性表达 纯化 Japanese encephalitis virus Envelope protein Soluble protein expression Purification
  • 相关文献

参考文献9

二级参考文献66

  • 1贾丽丽,郑铮,王志伟,俞永新.乙型脑炎减毒活疫苗(SA_(14)-14-2)在豚鼠体内保护作用的免疫机制的研究[J].微生物学免疫学进展,1995,23(2):73-76. 被引量:9
  • 2张雪寒,何孔旺,郭容利,倪艳秀,王芳,俞正玉.流行性乙型脑炎病毒E基因的克隆、表达及初步应用[J].中国病毒学,2005,20(5):494-497. 被引量:6
  • 3冯国和,窦晓光,王玉梅,周言.流行性乙型脑炎DNA疫苗研究新进展[J].国外医学(流行病学.传染病学分册),2005,32(6):368-370. 被引量:2
  • 4Rice CM. Flaviviridae: the viruses and their replication// Fields BN, Knipe M, Howley PM. Field's virology. Philadelphia: Lippincott-Raven Publications, 1996.
  • 5Chambers TJ, McCourt DW, Rice CM. Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinevtics using region-specific polyclonal antisera. Virology, 1990, 177 (1): 159-174.
  • 6Westaway EG, Mackenzie JM, Kenney MT, et al. Ultrastruture of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-strand RNA , and of NS2B with NS3, in virus-induced membrane structures. J Virol, 1997, 71 (9): 6650-6661.
  • 7Macdonald J, Tonry J, Hall RA, et al. NS1 protein secretion during the acute phase of West Nile virus infection. J Virol, 2005, 79 (22): 13924-13933.
  • 8Hall RA, Khromykh AA, Mackenzie JM. Loss of dimerisation of the nonstructural protein NSI of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1. Virology, 1999, 264 ( 1 ): 66-75.
  • 9Schlesinger J J, Brandriss MW, Walsh EE. Protection of mice against dengue 2 virus encephalitis by immunization with dengue 2 virus non-structural glycoprotein NSI. J Gen Virol, 1987, 68(Pt3): 853-857.
  • 10Schlesinger JJ, Foltzer M, Chapman S, et al. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against yellow fever encephalitis in mice. Virology, 1993, 192 ( 1 ): 132-141.

共引文献52

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部